(Q40144859)

17 September 2017

1 reference

title

The new low-osmolar contrast media: a simple guide (English)

1 reference

17 September 2017

The new low-osmolar contrast media: A simple guide (English)

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(83)80312-2

2 October 2023

author name string

P. Dawson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6337766

2 October 2023

R. G. Grainger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6337766

2 October 2023

J. Pitfield

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6337766

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6337766

2 October 2023

publication date

1 March 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0009926083803122?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(83)80312-2

https://api.elsevier.com/content/article/PII:S0009926083803122?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(83)80312-2

2 October 2023

1 reference

17 September 2017

volume

34

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

221-226

1 reference

Adverse reactions to contrast agents. Scope of problem

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

The current status of reactions to intravenous contrast media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Evidence supporting an antibody mediation of contrast media reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Contrast media and bronchospasm: a study with iopamidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

A comparison of iopamidol and diatrizoate in peripheral angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

A clinical trial of a new low osmolality contrast medium. Sodium and meglumine ioxaglate (Hexabrix) compared with meglumine iothalamate (Conray) for carotid arteriography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Osmolality of intravascular radiological contrast media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Intravascular contrast media--the past, the present and the future. Mackenzie Davidson Memorial Lecture, April 1981.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Contrast media reactions: data analysis and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Activation systems in contrast idiosyncrasy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

A randomized blind trial of Iopamidol and meglumine calcium metrizoate (Triosil 280, Isopaque Cerebral) in cerebral angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

Clinical cardiovascular experiences with iopamidol: a new non-ionic contrast medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2883%2980312-2

7 January 2021

Identifiers

1 reference

17 September 2017

1 reference